LIXT - Lixte Biotechnology Holdings Inc logo

LIXT

Lixte Biotechnology Holdings Inc

Rev โ€”top 1%10Y
Hold

Lixte Biotechnology Holdings develops cancer therapies targeting PP2A inhibitors, with its lead candidate LB-100 undergoing clinical trials for colorectal and ovarian cancers, and advanced soft tissue sarcoma, collaborating with several cancer research institutes.

โš•๏ธ Healthcare NASDAQ Listed 2007 $ USD
$1,000 invested 10 years ago โ†’$198today

Score Overview

1 Year
Scoreโ€”
Net Growth-21.04%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Scoreโ€”
Net Growth-8.11%
Net Trend60%
Net Income Consistencyโ€”
Rev Growthโ€”
Rev TrendNever
Revenue Consistencyโ€”
10 Years
Scoreโ€”
Net Growth-240.75%
Net Trend40%
Net Income Consistency
Rev Growthโ€”
Rev TrendNever
Revenue Consistency
All Time
Scoreโ€”
Net Growth-341.38%
Net Trend42%
Net Income Consistency
Rev Growthโ€”
Rev Trend8%
Revenue Consistency

See the full market ranking โ†’

Lixte Biotechnology Holdings Inc fundamental performance

Across Lixte Biotechnology Holdings Inc's full reported history, from 2007 to 2025, net income went from -$ 1M to -$ 6M. Revenue increased in 8% of the years measured; net income in 42%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-11
$ 3.56โ€”
1 Year2025-08-12
$ 4.85-26.60%
5 Years2021-08-12
$ 25.00-85.76%
10 Years2016-08-12
$ 18.00-80.22%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 0.00-$ 7M$ 3M
2025$ 0.00-$ 6M$ 5M
2024$ 0.00-$ 3M$ 1M
2023$ 0.00-$ 5M$ 4M
2022$ 0.00-$ 6M$ 5M
2021$ 0.00-$ 6M$ 4M
2020$ 0.00-$ 3M$ 5M
2019$ 0.00-$ 2M$ 2M
2018$ 0.00-$ 2M$ 4M
2017$ 0.00-$ 1M$ 1M
2016$ 0.00-$ 2M$ 199.93K
2015$ 200K-$ 2M$ 129.38K
2014$ 0.00-$ 2M$ 258.11K
2013-$ 1M$ 481.15K
2012-$ 3.58K$ 1M
2011-$ 2M$ 365.43K
2010-$ 880.25K$ 1M
2009-$ 1M$ 1M
2008-$ 1M$ 10.38K
IPO2007-$ 1M$ 508.07K

Explore beyond LIXT

You're looking at Lixte Biotechnology Holdings Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies